Titanium-nitride-oxide-coated coronary stents: insights from the available evidence

References

• Kastrati A, Hall D, Schömig A. Long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med. 2000;1:48–54.
   PubMedGoogle Scholar
• Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP, et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol. 2007;50:1299–304.
   PubMed Web of Science ®Google Scholar
• Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–30.
   PubMed Web of Science ®Google Scholar
• Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–78.
   PubMed Web of Science ®Google Scholar
• Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Ylitalo A, Airaksinen JK, Nammas W. Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new horizon for coronary intervention. Expert Rev Med Devices. 2010;7:599–604.
   PubMed Web of Science ®Google Scholar
• Karjalainen P, Nammas W. Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new breakthrough in interventional cardiology. Minerva Cardioangiol. 2011;59:447–54.
   PubMed Web of Science ®Google Scholar
• Steinemann SG. Metal implants and surface reactions. Injury. 1996;27(Suppl3):SC16–22.
   Google Scholar
• Zhang F, Chen Y, Zheng Z, Huang N, Liu X, Chen A, et al. Synthesis and blood compatibility of rutile-type titanium oxide coated LTI-carbon. Sci China C Life Sci. 1998;41:400–5.
   PubMedGoogle Scholar
• Xianghuai L, Zhihong Z, Zhuyao Z, Nan H, Ping Y, Guanjun C, et al. Surface modification of titanium based biomaterials by ion beam. J Biomater Appl. 1996;10:330–7.
   PubMed Web of Science ®Google Scholar
• Nan H, Ping Y, Xuan C, Yongxang L, Xiaolan Z, Guangjun C, et al. Blood compatibility of amorphous titanium oxide films synthesized by ion beam enhanced deposition. Biomaterials. 1998;19:771–6.
   PubMed Web of Science ®Google Scholar
• Huang N, Yang P, Leng Y. Surface modification of low temperature isotropic pyrolytic carbon artificial heart valve material. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 1999;16:127–31.
   PubMedGoogle Scholar
• Huang N, Chen YR, Luo JM, Yi J, Lu R, Xiao J, et al. In vitro investigation of blood compatibility of Ti with oxide layers of rutile structure. J Biomater Appl. 1994;8:404–12.
   PubMedGoogle Scholar
• Chen JY, Leng YX, Tian XB, Wang LP, Huang N, Chu PK, et al. Antithrombogenic investigation of surface energy and optical bandgap and hemocompatibility mechanism of Ti(Ta(+5))O2 thin films. Biomaterials. 2002;23:2545–52.
   PubMed Web of Science ®Google Scholar
• Huang N, Yang P, Leng YX, Chen JY, Sun H, Wang J, et al. Hemocompatibility of titanium oxide films. Biomaterials. 2003;24:2177–87.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zheng Z, Chen Y, Liu X, Chen A, Jiang Z. In vivo investigation of blood compatibility of titanium oxide films. J Biomed Mater Res. 1998;42:128–33.
   PubMed Web of Science ®Google Scholar
• Yeh HI, Lu SK, Tian TY, Hong RC, Lee WH, Tsai CH. Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res A. 2006;76:835–41.
   PubMed Web of Science ®Google Scholar
• Tsyganov I, Maitz MF, Wieser E, Richter E, Reuther H. Correlation between blood compatibility and physical surface properties of titanium-based coatings. Surface Coat Technol. 2005;200:1041–4.
   Web of Science ®Google Scholar
• Tsyganov IA, Maitz MF, Richter E, Reuther H, Mashina AI, Rustichelli F. Hemocompatibility of titanium-based coatings prepared by metal plasma immersion ion implantation and deposition. Beam Interact Mater Atoms. 2007;257:122–7.
   Web of Science ®Google Scholar
• Windecker S, Billinger M, Hess OM. Stent coating with titanium-nitride-oxide for prevention of restenosis. EuroIntervention. 2006;2:146–8.
   PubMedGoogle Scholar
• Windecker S, Mayer I, De Pasquale G, Maier W, Dirsch O, De Groot P, et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation. 2001;104:928–33.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation. 2001;104:1188–93.
   PubMed Web of Science ®Google Scholar
• Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M, et al. Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation. 2005;111:2617–22.
   PubMed Web of Science ®Google Scholar
• Sansa M, Cernigliaro C, Bongo AS, Rosso R, Giacomarra G, Campi A, et al. Comparison randomisée de l'utilisation de stents couverts au Titane-Nitride-Oxyde dans l'ischémie aiguë: effets sur la thrombose précoce et tardive, et sur la resténose angiographique. Arch Mal Coeur Vaiss. 2005;98(Abs).
   Google Scholar
• Pilgrim T, Räber L, Limacher A, Löffel L, Wenaweser P, Cook S, et al. Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trial. JACC Cardiovasc Interv. 2011;4:672–82.
   PubMed Web of Science ®Google Scholar
• López-Mínguez JR, Nogales-Asensio JM, Doncel-Vecino LJ, Merchán-Herrera A, Pomar-Domingo F, Martínez-Romero P, et al. A randomized study to compare bioactive titanium stents and everolimus-eluting stents in diabetic patients (TITANIC XV): 1-year results. Rev Esp Cardiol (Engl Ed). 2014;67:522–30.
   PubMed Web of Science ®Google Scholar
• Valdés Chavarri M, Bethencourt A, Pinar E, Gomez A, Portales JF, Pomar F, et al. Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry. Heart Vessels. 2012;27:151–8.
   PubMed Web of Science ®Google Scholar
• Mosseri M, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A, et al. Short- and long-term outcomes of the titanium-NO stent registry. Cardiovasc Revasc Med. 2005;6:2–6.
   PubMedGoogle Scholar
• Mosseri M, Miller H, Tamari I, Plich M, Hasin Y, Brizines M, et al. The titanium-NO stent: results of a multicenter registry. EuroIntervevtion. 2006;2:192–6.
   PubMedGoogle Scholar
• Karjalainen PP, Ylitalo AS, Airaksinen JKE. Real world experience with the TITAN(R) stent: a 9-month follow-up report from the Titan PORI Registry. EuroIntervention. 2006;2:187–91.
   PubMedGoogle Scholar
• Angioi M, Barragan P, Cattan S, Collet F, Dupouy P, Durand P, et al. French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry. Arch Cardiovasc Dis. 2012;105:60–7.
   PubMed Web of Science ®Google Scholar
• Valdesuso R, Karjalainen P, García J, Díaz J, Portales JF, Masotti M, et al. The EXTREME registry: titanium-nitride-oxide coated stents in small coronary arteries. Catheter Cardiovasc Interv. 2010;76:281–7.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Mikkelsson J, Ylitalo A, Paana T, Nammas W. Mid-term clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: OPTIMAX first-in-man study. Rev Esp Cardiol (Engl Ed). 2014;67:958–9.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Mikkelsson J, Paana T, Nammas W. Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study. Catheter Cardiovasc Interv. 2016;87:E122–7.
   Google Scholar
• Karjalainen PP, Ylitalo A, Airaksinen JK. Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. J Invasive Cardiol. 2006;18:462–8.
   PubMedGoogle Scholar
• Karjalainen PP, Annala AP, Ylitalo A, Vahlberg T, Airaksinen KE. Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int J Cardiol. 2010;144:42–6.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Ylitalo A, Airaksinen JK, Nammas W. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry. J Interven Cardiol. 2011;24:1–8.
   PubMed Web of Science ®Google Scholar
• Limacher A, Räber L, Laube E, Lauterburg A, Lötscher S, Hess N, et al. Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis. EuroIntervention. 2012;7:1043–50.
   PubMed Web of Science ®Google Scholar
• Osterne TEC, Pimentel Filho WA, Curado FAMC, Bocchi EA, Custódio WB, de Matos GMG, et al. Performance of the titanium-nitride-oxide coated stent in patients with multivessel coronary artery disease. Revista Brasileira De Cardiologia Invasiva. 2014;22:143–8.
   Google Scholar
• Garcia-Gutierrez JC, Palacios-Rodríguez JM, Cordova-Correa HG, Becerra-Laguna CA, López-López HA, Salinas Aragón MA, et al. Experience with the use of the bio-active stent coated with titanium nitric oxide compared with zotarolimus-eluting stent: experience of a unit medical high specialty. Arch Cardiol Mex. 2016;86:18–25.
   PubMedGoogle Scholar
• Moschovitis A, Simon R, Seidenstücker A, Klauss V, Baylacher M, Lüscher TF, et al. Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial. EuroIntervention. 2010;6:63–8.
   PubMed Web of Science ®Google Scholar
• Sant’Anna FM, Batista LA, Brito MB, Menezes S, Ventura FM, Buczynski L, et al. Randomized comparison of percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus stainless steel stents in patients with coronary artery disease: RIO trial. Rev Bras Cardiol Invas. 2009;17:69–75.
   Google Scholar
• Karjalainen PP, Ylitalo A, Niemelä M, Kervinen K, Mäkikallio T, Pietili M, et al. Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. EuroIntervevtion. 2008;4:234–41.
   PubMedGoogle Scholar
• Karjalainen PP, Ylitalo A, Niemela M, Kervinen K, Makikallio T, Pietila M, et al. Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Ann Med. 2009;21:1–9.
   Google Scholar
• Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, et al. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial. Int J Cardiol. 2013;168:1214–19.
   PubMed Web of Science ®Google Scholar
• Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, et al. Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial. J Invasive Cardiol. 2012;24:104–8.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Niemelä M, Airaksinen JK, Rivero-Crespo F, Romppanen H, Sia J, et al. A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial. EuroIntervention. 2012;8:306–15.
   PubMed Web of Science ®Google Scholar
• Romppanen H, Nammas W, Kervinen K, Airaksinen JK, Pietilä M, Rivero-Crespo F, et al. Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial. Ann Med. 2013;45:488–93.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Niemelä M, Pietilä M, Sia J, de Belder A, Rivero-Crespo F, et al. 4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome. Scand Cardiovasc J. 2016;50:218–23.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Nammas W, Ylitalo A, de Bruyne B, Lalmand J, de Belder A, et al. Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: final report of the BASE ACS trial. Int J Cardiol. 2016;222:275–80.
   PubMed Web of Science ®Google Scholar
• Romppanen H, Nammas W, Kervinen K, Mikkelsson J, Pietilä M, Lalmand J, et al. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial. Minerva Cardioangiol. 2013;61:201–9.
   PubMed Web of Science ®Google Scholar
• Sia J, Nammas W, Niemelä M, Airaksinen JK, Lalmand J, Laine M, et al. Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome. J Cardiovasc Med. 2015;16:197–203.
   Google Scholar
• Karjalainen PP, Airaksinen JK, de Belder A, Romppanen H, Kervinen K, Sia J, et al. Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial. Ann Med. 2016;48:376–83.
   PubMed Web of Science ®Google Scholar
• Nammas W, de Belder A, Niemelä M, Sia J, Romppanen H, Laine M, et al. Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly. Eur J Intern Med. 2016; ‘in press’.
   PubMed Web of Science ®Google Scholar
• Nammas W, Airaksinen JK, Romppanen H, Sia J, de Belder A, Karjalainen PP. Impact of preexisting vascular disease on the outcome of patients with acute coronary syndrome: insights from the comparison of bioactive stent to the everolimus-eluting stent in acute coronary syndrome trial. Angiology. 2016; ‘in press’.
   PubMedGoogle Scholar
• Tuomainen PO, Sia J, Nammas W, Niemelä M, Airaksinen JK, Biancari F, et al. Pooled analysis of two randomized trials comparing titanium-nitride-oxide-coated stent versus drug-eluting stent in STEMI. Rev Esp Cardiol (Engl Ed). 2014;67:531–7.
   PubMed Web of Science ®Google Scholar
• Pilgrim T, Räber L, Limacher A, Wenaweser P, Cook S, Stauffer JC, et al. Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation. EuroIntervention. 2015;10:1284–7.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Biancari F, Ylitalo A, Raeber L, Billinger M, Hess O, et al. Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting. J Invasive Cardiol. 2010;22:322–6.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Nammas W. Excellent very early neointimal coverage of bioactive stents by optical coherence tomography. Scand Cardiovasc J. 2015;49:280–5.
   PubMed Web of Science ®Google Scholar
• Annala AP, Lehtinen T, Kiviniemi TO, Ylitalo A, Nammas W, Karjalainen PP. Vascular healing early after titanium-nitride-oxide-coated stent implantation assessed by optical coherence tomography. J Invasive Cardiol. 2013;25:186–9.
   PubMed Web of Science ®Google Scholar
• Lehtinen T, Airaksinen KE, Ylitalo A, Karjalainen PP. Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study. Int J Cardiovasc Imaging. 2012;28:1859–66.
   PubMed Web of Science ®Google Scholar
• Karjalainen P, Kiviniemi TO, Lehtinen T, Nammas W, Ylitalo A, Saraste A, et al. Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial. Int J Cardiovasc Imaging. 2013;29:1693–703.
   PubMed Web of Science ®Google Scholar
• Varho V, Kiviniemi TO, Nammas W, Sia J, Romppanen H, Pietilä M, et al. Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome. Int J Cardiovasc Imaging. 2016;32:1031–9.
   PubMed Web of Science ®Google Scholar
• Colkesen EB, Eefting FD, Rensing BJ, Suttorp MJ, Ten Berg JM, Karjalainen PP, et al. TIDES-ACS Trial: comparison of titanium-nitride-oxide coated bio-active-stent to the drug (everolimus)-eluting stent in acute coronary syndrome. Study design and objectives. Minerva Cardioangiol. 2015;63:21–9.
   PubMed Web of Science ®Google Scholar
• Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–619.
   PubMed Web of Science ®Google Scholar
• Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371:2155–66.
   PubMed Web of Science ®Google Scholar